| Systematic (IUPAC) name | |
|---|---|
| 1-Cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | veterinary use only |
| Routes | Oral |
| Identifiers | |
| CAS number | 113617-63-3 |
| ATCvet code | QJ01MA95 |
| PubChem | CID 60605 |
| ChemSpider | 54631 |
| UNII | 660932TPY6 |
| KEGG | D08299 |
| ChEMBL | CHEMBL295433 |
| Chemical data | |
| Formula | C19H20F3N3O3 |
| Mol. mass | 395.37 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Orbifloxacin (brand name Orbax) is a fluoroquinolone antibiotic which is approved for use in dogs,[1] marketed by Schering-Plough Animal Health.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
| This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)